2024 Nobel in Chemistry for “Designing protein” and “Predicting protein structure”  

One half of the Nobel Prize in Chemistry 2024 has been awarded to David Baker “for computational protein design”. The other half has been awarded jointly to Demis Hassabis and John M. Jumper “for protein structure prediction”.  

The Nobel Prize in Chemistry 2024 recognises contributions towards our ability to predict protein structures and design new proteins.  

One half of the Prize has been awarded to David Baker “for computational protein design”. In 2003, he built entirely new kinds of proteins using 20 diffrent amino acids. The new proteins were unlike any other proteins and have applications as pharmaceuticals, vaccines, nanomaterials and tiny sensors. 

The other half has been awarded jointly to Demis Hassabis and John M. Jumper “for protein structure prediction”. In 2020, they successfully developed an AI model called AlphaFold2 for predicting complex three-dimensional structures of proteins from atheir mino acid sequences. Their AI model predicts structure of all the 200 million proteins identified so far. This ability is helpful in better understanding of antibiotic resistance and in creating images of enzymes that can decompose plastic.  

*** 

Sources:  

  1. NobelPrize.org. Press release – The Nobel Prize in Chemistry 2024. Posted 9 October 2024. Available at https://www.nobelprize.org/prizes/chemistry/2024/press-release/  

*** 

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Circular Solar Halo

Circular Solar Halo is an optical phenomenon seen in...

Craspase : a new safer “CRISPR – Cas System” that edits both Genes and Proteins  

“CRISPR-Cas systems” in bacteria and viruses identify and destroy invading...

Chemistry Nobel Prize 2023 for the discovery and synthesis of Quantum dots  

This year’s Nobel Prize in Chemistry has been awarded...

Homo sapiens spread into cold steppes in northern Europe 45,000 years ago 

Homo sapiens or the modern human evolved around 200,000...

A New Easy Treatment for Peanut Allergy

A promising new treatment using immunotherapy to treat peanut...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.